ClinicalTrials.gov
public full text
Public Domain
The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC#321712
- Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin#1164363
- Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer#897717
- Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC#1008538
- Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML#900843
Record · ID 426763
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive